Promoting informed decision making about prostate cancer screening.
Because prostate cancer screening with prostate specific antigen is controversial, informed consent is recommended. Physicians are encouraged to discuss facts about prostate specific antigen with patients and to supplement such discussions with informational brochures or videotapes.
Chan
E C
EC
Division of General Internal Medicine, Department of Medicine, University of Texas-Houston Health Science Center, 6431 Fannin, 1.122 MSB, Houston, TX 77030, USA.
D015415:Biomarkers; D003657:Decision Making; D006801:Humans; D007258:Informed Consent; D008297:Male; D008403:Mass Screening / Q000523:psychology*; D010353:Patient Education as Topic / Q000379:methods; D010817:Physician-Patient Relations; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D014481:United States
D015415:Biomarkers; D017430:Prostate-Specific Antigen